GLP-1 and protein on PCOS: what the TikTok buzz gets right

What did @thebridgetteanastasia actually say?

She reached 15mg tirzepatide (Zepbound/Mounjaro), the highest approved dose, and found it less dramatic than expected. "The appetite suppression would be crazy, and I would be losing weight like crazy, but it really isn't," she said. She's asking whether the drug will "wear off" like previous doses did, and whether there's a plan B. Her current strategy: high protein intake and weightlifting five days a week to preserve muscle mass. She notes her provider told her many patients stay on 15mg long-term and still lose weight successfully. This is a genuinely relatable account of a real clinical experience, and she's not overselling the drug or making wild claims. Credit where it's due: she's being pretty honest about what GLP-1 therapy actually feels like for a lot of people.

Does the science back this up?

Yes, mostly. The plateau effect she describes is documented. Effects don't keep escalating with every dose increase, and individual response varies considerably. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide 15mg produced mean weight loss of around 22.5% body weight over 72 weeks, but that's a population average with wide individual variation. Some participants lost significantly less.

The "wearing off" phenomenon she's describing has a more precise name: dose-response attenuation. Your body adapts. GLP-1 and GIP receptor sensitivity doesn't stay static. A 2023 paper by Müller et al. in Nature Reviews Drug Discovery noted that receptor downregulation and adaptive metabolic responses can blunt appetite suppression over time. This is why maintenance dosing is a real clinical challenge, not a marketing problem.

Her protein and resistance training approach is also well-supported. Churchward-Venne et al. (2012, American Journal of Clinical Nutrition) and more recent GLP-1-specific work consistently show that without adequate protein and resistance training, GLP-1-driven weight loss includes substantial lean mass loss, sometimes 25-40% of total weight lost.

What did they get right, and what's missing?

She gets several things right. Acknowledging that 15mg is not a magic ceiling, talking to her provider, and prioritizing protein and weightlifting are all clinically sound moves. The provider's comment that many patients succeed long-term on 15mg is accurate based on trial data.

What's missing: she frames "wearing off" as something that just happens passively, without discussing what can actually be done about it. Clinical options when someone plateaus at maximum dose include behavioral recalibration, structured diet breaks, or in some cases transition to a different agent. She says "do we have a plan B" but doesn't explore what that might look like. That's fine for a TikTok, but viewers who are on the same journey might need to know that a plateau is not the end of the road.

She also uses "Tresaptide" in the transcript, which is likely a spoken approximation of tirzepatide. Not a factual error, just worth clarifying for viewers who might search that term and find nothing.

What should you actually know?

If you're on 15mg tirzepatide and feeling like it's less powerful than expected, you're not imagining it and you're not alone. The SURMOUNT-3 trial (Wadden et al., 2023, NEJM) showed that intensive lifestyle intervention layered on top of tirzepatide significantly improved outcomes compared to drug alone. Her instinct to double down on protein and resistance training is backed by that data.

One thing the video doesn't address: how you define "working." Appetite suppression being less intense doesn't mean the drug isn't doing anything metabolically. Tirzepatide has documented effects on insulin sensitivity, gastric emptying, and energy expenditure that continue even when you stop noticing the hunger suppression as acutely.

• Plateaus at maximum dose are common and clinically expected, not a sign of failure.
• Muscle preservation during GLP-1 therapy requires intentional protein intake and resistance training, not just the drug.
• A plan B exists and should be discussed with your prescriber before you hit a wall, not after.
• "Wearing off" is real but imprecise. What changes is often receptor sensitivity and adaptive appetite responses, not the drug's entire mechanism.